Navigation Links
Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection
Date:2/6/2012

mercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit www.cadencepharm.com.

Forward-Looking Statements Statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "plans," "believes," "expects," "anticipates," and "will," and similar expressions, are intended to identify forward-looking statements, and are based on Cadence's current beliefs and expectations. Such statements include, without limitation, statements regarding: estimates of the number of vials of lot V005710 that currently remain in the marketplace and expectations regarding the supply of OFIRMEV. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Cadence's actual future results may differ materially from the company's current expectations due to the risks and uncertainties inherent in its business. These risks include, but are not limited to: Cadence's dependence on the successful commercialization of OFIRMEV, which is its only product; Cadence's ability to ensure an adequate and continued supply of OFIRMEV to meet anticipated market demand; the risk that if Cadence's contract manufacturers fail to meet its requirements for OFIRMEV, Cadence may be unable to meet market demand and may lose potential revenues; the potential that customers' perception of OFIRMEV or Cadence's relationships with its customers may be damaged by the recall; costs, re-stocking expenses and potential product liability claims that may be associated with the recall; the potential for additional recalls,  supply disruptions, or manufacturing changes for OFIRMEV; and other risks detailed under "Risk Factors" and elsewhere in Cadence's periodic reports and other filings made with the Securities and Exchange Commission from time to time. All forward-looking s
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
2. Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters
3. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011
6. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
7. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
8. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
9. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
10. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
11. Cadence, Inc. Announces Major Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 Vanda Pharmaceuticals Inc. ... data today at ENDO 2013, the Endocrine Society,s ... can entrain (synchronize) both melatonin and cortisol rhythms. ... the master body clock and address the circadian ... The SET (Safety and Efficacy of Tasimelteon) and ...
(Date:6/17/2013)... Quebec , June 17, 2013 Valeant Pharmaceuticals ... announced today that it has filed a preliminary prospectus supplement ... has today made a similar filing with securities regulatory authorities ... in connection with a public offering of its common ... "Offering"). The Company will also grant to the ...
(Date:6/17/2013)... NEW YORK , June 17, 2013 The ... and CEO, The Partnership at Drugfree.org :   ... to CNN that it was halting the sale of prescription ... of product we recognize that from time to time there ... are not our customer. As a result of this misinterpretation ...
Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2
... UL, a world leader in advancing ... testing GmbH (MDT) and md registration support Ltd. (MDRS).  These ... UL,s Life and Health business unit.   MDT ... the medical services industry.  MDT specializes in clinical and non-clinical ...
... 2011 Apnex Medical, Inc., received investigational device exemption ... (FDA) to begin a clinical study to evaluate the ... System to treat obstructive sleep apnea (OSA). Data from ... Approval (PMA) application for the HGNS System to the ...
Cached Medicine Technology:UL Expands Presence in Medical Device Market With Acquisition of MDT 2UL Expands Presence in Medical Device Market With Acquisition of MDT 3Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 3
(Date:6/18/2013)... 2013 Seven-year-old Riley Salz of Encino, ... He receives 40 hours a week of applied behavior ... the Center for Autism and Related Disorders (CARD). Riley ... and has experienced remarkable progress, including learning to speak, ... Riley’s personal journey through autism is now featured in ...
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... More than 1.1 million people in the ... to the Centers for Disease Control and Prevention (CDC). Of ... support of National HIV Testing Day on June 27, Allsup, ... (SSDI) representation, the CDC and other organizations are raising awareness ... reports about 50,000 new HIV infections each year. Along with ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 myCNAjobs announces ... of free downloads, articles, and tips to the Caregiver ... to care for the 10,000+ retiring baby boomers each ... professional caregiver job resources has never been ... CNA job community, recently launched the first-ever free ...
(Date:6/18/2013)... A new $119 million industry is taking ... is redefining the way consumers get their seafood. ... culinary chefs on the Emerald Coast panhandle of Northwest ... and the promising industry of aquaculture. , The word ... strive to fully partake in the effort, especially when ...
Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:New $119 Million Industry Swimming Up the East Coast 2
... -- Men with low testosterone levels may be at increased ... a finding that challenges the current belief that testosterone is ... The study included 930 men with coronary artery disease ... of the study, low testosterone levels were noted in about ...
... ARBOR, Mich. Millions worldwide die each year because they ... States say they,d be willing to donate theirs after death ... Circulation, experts at the University of Michigan Cardiovascular ... they are removed for burial or cremation, for sterilization and ...
... Reinberg HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay ... mothers and their infants from taking supplemental fish oil in ... finds no such benefit. In this large randomized, ... found no benefit from DHA in reducing levels of postpartum ...
... 19 (HealthDay News) -- Kidney-failure patients can continue taking a ... study showed they can increase the risk of stroke, U.S. ... and Drug Administration advisers voted 15-1, with one abstention, to ... disease who aren,t yet in need of dialysis, the ...
... Medicine investigated the role between adiponectin and leptin in ... issue of Hepatology , suggest that the protein ... of leptin, namely in hepatocellular carcinoma (HCC), and could ... Obesity is on the rise and is associated with ...
... Neuralstem, Inc. (NYSE Amex: CUR) updated the progress of ... company,s spinal cord stem cells in the treatment of ... Emory University in Atlanta, Georgia. The company announced that, ... non-ambulatory patients, the trial,s Safety Monitoring Board has unanimously ...
Cached Medicine News:Health News:Low Testosterone May Raise Risk of Early Death: Study 2Health News:Recycling pacemakers may alleviate burden of heart disease across the globe 2Health News:Recycling pacemakers may alleviate burden of heart disease across the globe 3Health News:Fish Oil Pills Don't Affect Postpartum Depression: Study 2Health News:Fish Oil Pills Don't Affect Postpartum Depression: Study 3Health News:Fish Oil Pills Don't Affect Postpartum Depression: Study 4Health News:FDA Advisers Back Anemia Drugs for Kidney Patients 2Health News:FDA Advisers Back Anemia Drugs for Kidney Patients 3Health News:FDA Advisers Back Anemia Drugs for Kidney Patients 4Health News:Adiponectin shows potential in blocking obesity-related carcinogenesis 2Health News:Neuralstem updates ALS clinical trial progress 2
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... The PowerLab/16SP is a high-performance recording unit ... science research applications that require up to ... and isolated tissue studies. The unit is ... to 200 000 samples per second continuously ...
Three Figure Worth Type Test, this test is used for determining diplopia, suppression or fusion in children. Sturdy chrome flashlight comes with red/green glasses. Requires 3 D batteries which are no...
Medicine Products: